Lung Cancers Completed Phase 1 Trials for Topotecan (DB01030)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00287963Topotecan and Vinorelbine in Treating Patients With Recurrent Lung CancerTreatment
NCT00466232Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung CancerTreatment
NCT00388089Bortezomib and Topotecan in Treating Patients With Advanced Solid TumorsTreatment
NCT00315861Topotecan in Combination With Pemetrexed in Patients With Advanced MalignanciesTreatment
NCT00322751Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung CancerTreatment
NCT00002537Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung CancerTreatment
NCT00002625Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaTreatment